Cleared Traditional

K972140 - A1 ACOUSTIC RHINOMETER

K972140 is an FDA 510(k) clearance for A1 ACOUSTIC RHINOMETER, manufactured by G.M. Instruments , Ltd.. The device is a Class 2 Anesthesiology device with product code BXQ cleared through the Traditional 510(k) pathway after a 481-day FDA review.

K972140 · G.M. Instruments , Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1998
Decision
481d
Days
Class 2
Risk

K972140 is an FDA 510(k) clearance for the A1 ACOUSTIC RHINOMETER. Classified as Rhinoanemometer (measurement Of Nasal Decongestion) (product code BXQ), Class II - Special Controls.

Submitted by G.M. Instruments , Ltd. (Kilwinning, GB). The FDA issued a Cleared decision on September 30, 1998 after a review of 481 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1800 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all G.M. Instruments , Ltd. devices

FDA 510(k) Submission Details - K972140

510(k) Number K972140 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 1997
Decision Date September 30, 1998
Days to Decision 481 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
341d slower than avg
Panel avg: 140d · This submission: 481d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BXQ Device Classification - Class 2, Special Controls

Product Code BXQ Rhinoanemometer (measurement Of Nasal Decongestion)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BXQ Rhinoanemometer (measurement Of Nasal Decongestion)

Devices cleared under the same product code (BXQ) and FDA review panel - the closest regulatory comparables to K972140.
VISIONAIR
K221892 · Pacificmd Biotech, LLC · Oct 2022
SGS ECCOVISIONTM Pharyngometer, SGS ECCOVISIONTM Rhinometer, SGS ECCOVISIONTM Rhino/Pharyngometer
K170071 · Sleep Group Solutions · Nov 2017
ACOUSTIC RHINOMETER
K921452 · Hood Laboratories · Jul 1993
MERCURY RHINOMANOMETER
K902120 · Life-Tech Intl., Inc. · Aug 1990
RHINOMANOMETER
K896263 · Jedmed Instrument Co. · Apr 1990